New Delhi, April 28: The Indian Council of Medical Research (ICMR) on Tuesday said that Convalescent plasma is one of the several emerging therapies, however, there is no evidence to support it that it can treat coronavirus disease.
The ICMR stated that currently there are no approved definitive therapies for the treatment of COVID-19.
“Convalescent plasma therapy comes with its own share of technical challenges, like antibody titer testing. There are also several risks of using this therapy including life-threatening allergic reactions and lung injury,” the ICMR stated.
Given the serious uncertainties around #COVID19 convalescent plasma therapy, ICMR has initiated a multi-center clinical trial to evaluate the safety and efficacy of using this therapy in COVID-19 patients in India. Despite the threat of Novel Coronavirus pandemic, there’s a need to ensure the ethical integrity and establish the scientific basis of using COVID-19 convalescent plasma therapy in patients, the ICMR stated.